trending Market Intelligence /marketintelligence/en/news-insights/trending/HhbMzl6IKAp5be6Ebk9Wqg2 content esgSubNav
In This List

Merrimack names chief medical officer

Blog

Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Insight Weekly: Path to net-zero; US manufacturing momentum; China's lithium M&A frenzy


Merrimack names chief medical officer

Sergio Santillana will become Merrimack Pharmaceuticals Inc.'s chief medical officer on June 12.

Santillana is the former chief medical officer at ARIAD Pharmaceuticals.